Roquefort Therapeutics plc (LON:ROQ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.225
-0.125 (-9.26%)
Jan 22, 2026, 8:26 AM GMT
-68.18%
Market Cap2.21M
Revenue (ttm)n/a
Net Income (ttm)-882.45K
Shares Out163.73M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume537,180
Average Volume953,005
Open1.290
Previous Close1.350
Day's Range1.225 - 1.290
52-Week Range1.076 - 4.500
Beta-0.52
RSI51.55
Earnings DateDec 29, 2025

About Roquefort Therapeutics

Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics for solid tumors; STAT-6 siRNA therapeutics targeting solid tumors with significance in v... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 7
Stock Exchange London Stock Exchange
Ticker Symbol ROQ
Full Company Profile

Financial Performance

Financial Statements